Involvement of NFκB in the production of chemokines by rat and human conjunctival cells cultured under allergenic conditions

Osamu Sakai, Yoshiyuki Tamada, Thomas (Tom) Shearer, Mitsuyoshi Azuma

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: The purpose of present studies was to determine the involvement of NFκB and STAT6 transcription factors in the production of cytokines by the fibroblasts and epithelial cells in conjunctiva. Methods: An in vitro model of allergic conjunctivitis was developed by sensitizing and challenging rat mast cells with anti-dinitrophenyl (DNP) IgE and DNP-BSA, and then using the conditioned medium to stimulate rat conjunctival fibroblasts. Chemokines (eotaxin-1, IL-8, and RANTES - Regulated and Normal T cell Expressed and Secreted) released from cells into the medium was determined by ELISA. Human conjunctival fibroblasts and epithelial cells were also directly stimulated with exogenous cytokines tumor necrosis factor (TNF)-α or IL-4. Degradation of IκB-α and phosphorylation of STAT6 were assessed by immunoblotting. For inhibition of NFκB or STAT6 activation, upstream regulators IκB kinase and Janus protein tyrosine kinases (JAK) were inhibited by use of BMS-345541 and JAK inhibitor 1. An in vivo model of conjunctivitis was also produced in rats by intraperitoneal injection of ovalbumin (OA) with aluminum hydroxide and challenge at 21d with OA eye drops. Results: Stimulated rat mast cells released TNF-α and IL-4. TNF-α induced NFκB activation in rat and human conjunctival fibroblasts and epithelial cells, and caused production and release of cytokines IL-8 and RANTES. IL-4 activation of STAT6 did not cause release of these cytokines. Only fibroblasts produced the eosinophil-recruiting cytokine, eotaxin-1, after treatment with TNF-α- plus IL-4. As observed in the cultured cells, allergic stimulation in the in vivo model caused degradation of IκB-α in conjunctiva, and infiltration of eosinophils and other inflammatory cells. Conclusion: Activated NFκB was found to be a major transcription factor for the release of cytokines from conjunctival cells and intensification of the allergic response. Inhibition of the NFκB pathway by therapeutic drugs may be an important objective for the treatment of human allergic conjunctivitis.

Original languageEnglish (US)
Pages (from-to)825-834
Number of pages10
JournalCurrent Eye Research
Volume38
Issue number8
DOIs
StatePublished - Aug 2013

Fingerprint

Chemokines
Cultured Cells
Cytokines
Fibroblasts
Interleukin-4
Chemokine CCL11
Tumor Necrosis Factor-alpha
Allergic Conjunctivitis
Chemokine CCL5
Epithelial Cells
Conjunctiva
Ovalbumin
Interleukin-8
Eosinophils
Mast Cells
STAT6 Transcription Factor
Janus Kinases
Aluminum Hydroxide
Conjunctivitis
Ophthalmic Solutions

Keywords

  • Allergic conjunctivitis
  • Chemokine
  • Conjunctival cells
  • Mast cells
  • NFκB

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Involvement of NFκB in the production of chemokines by rat and human conjunctival cells cultured under allergenic conditions. / Sakai, Osamu; Tamada, Yoshiyuki; Shearer, Thomas (Tom); Azuma, Mitsuyoshi.

In: Current Eye Research, Vol. 38, No. 8, 08.2013, p. 825-834.

Research output: Contribution to journalArticle

@article{fd749b2217684d3b804721b9416d0441,
title = "Involvement of NFκB in the production of chemokines by rat and human conjunctival cells cultured under allergenic conditions",
abstract = "Purpose: The purpose of present studies was to determine the involvement of NFκB and STAT6 transcription factors in the production of cytokines by the fibroblasts and epithelial cells in conjunctiva. Methods: An in vitro model of allergic conjunctivitis was developed by sensitizing and challenging rat mast cells with anti-dinitrophenyl (DNP) IgE and DNP-BSA, and then using the conditioned medium to stimulate rat conjunctival fibroblasts. Chemokines (eotaxin-1, IL-8, and RANTES - Regulated and Normal T cell Expressed and Secreted) released from cells into the medium was determined by ELISA. Human conjunctival fibroblasts and epithelial cells were also directly stimulated with exogenous cytokines tumor necrosis factor (TNF)-α or IL-4. Degradation of IκB-α and phosphorylation of STAT6 were assessed by immunoblotting. For inhibition of NFκB or STAT6 activation, upstream regulators IκB kinase and Janus protein tyrosine kinases (JAK) were inhibited by use of BMS-345541 and JAK inhibitor 1. An in vivo model of conjunctivitis was also produced in rats by intraperitoneal injection of ovalbumin (OA) with aluminum hydroxide and challenge at 21d with OA eye drops. Results: Stimulated rat mast cells released TNF-α and IL-4. TNF-α induced NFκB activation in rat and human conjunctival fibroblasts and epithelial cells, and caused production and release of cytokines IL-8 and RANTES. IL-4 activation of STAT6 did not cause release of these cytokines. Only fibroblasts produced the eosinophil-recruiting cytokine, eotaxin-1, after treatment with TNF-α- plus IL-4. As observed in the cultured cells, allergic stimulation in the in vivo model caused degradation of IκB-α in conjunctiva, and infiltration of eosinophils and other inflammatory cells. Conclusion: Activated NFκB was found to be a major transcription factor for the release of cytokines from conjunctival cells and intensification of the allergic response. Inhibition of the NFκB pathway by therapeutic drugs may be an important objective for the treatment of human allergic conjunctivitis.",
keywords = "Allergic conjunctivitis, Chemokine, Conjunctival cells, Mast cells, NFκB",
author = "Osamu Sakai and Yoshiyuki Tamada and Shearer, {Thomas (Tom)} and Mitsuyoshi Azuma",
year = "2013",
month = "8",
doi = "10.3109/02713683.2013.780623",
language = "English (US)",
volume = "38",
pages = "825--834",
journal = "Current Eye Research",
issn = "0271-3683",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Involvement of NFκB in the production of chemokines by rat and human conjunctival cells cultured under allergenic conditions

AU - Sakai, Osamu

AU - Tamada, Yoshiyuki

AU - Shearer, Thomas (Tom)

AU - Azuma, Mitsuyoshi

PY - 2013/8

Y1 - 2013/8

N2 - Purpose: The purpose of present studies was to determine the involvement of NFκB and STAT6 transcription factors in the production of cytokines by the fibroblasts and epithelial cells in conjunctiva. Methods: An in vitro model of allergic conjunctivitis was developed by sensitizing and challenging rat mast cells with anti-dinitrophenyl (DNP) IgE and DNP-BSA, and then using the conditioned medium to stimulate rat conjunctival fibroblasts. Chemokines (eotaxin-1, IL-8, and RANTES - Regulated and Normal T cell Expressed and Secreted) released from cells into the medium was determined by ELISA. Human conjunctival fibroblasts and epithelial cells were also directly stimulated with exogenous cytokines tumor necrosis factor (TNF)-α or IL-4. Degradation of IκB-α and phosphorylation of STAT6 were assessed by immunoblotting. For inhibition of NFκB or STAT6 activation, upstream regulators IκB kinase and Janus protein tyrosine kinases (JAK) were inhibited by use of BMS-345541 and JAK inhibitor 1. An in vivo model of conjunctivitis was also produced in rats by intraperitoneal injection of ovalbumin (OA) with aluminum hydroxide and challenge at 21d with OA eye drops. Results: Stimulated rat mast cells released TNF-α and IL-4. TNF-α induced NFκB activation in rat and human conjunctival fibroblasts and epithelial cells, and caused production and release of cytokines IL-8 and RANTES. IL-4 activation of STAT6 did not cause release of these cytokines. Only fibroblasts produced the eosinophil-recruiting cytokine, eotaxin-1, after treatment with TNF-α- plus IL-4. As observed in the cultured cells, allergic stimulation in the in vivo model caused degradation of IκB-α in conjunctiva, and infiltration of eosinophils and other inflammatory cells. Conclusion: Activated NFκB was found to be a major transcription factor for the release of cytokines from conjunctival cells and intensification of the allergic response. Inhibition of the NFκB pathway by therapeutic drugs may be an important objective for the treatment of human allergic conjunctivitis.

AB - Purpose: The purpose of present studies was to determine the involvement of NFκB and STAT6 transcription factors in the production of cytokines by the fibroblasts and epithelial cells in conjunctiva. Methods: An in vitro model of allergic conjunctivitis was developed by sensitizing and challenging rat mast cells with anti-dinitrophenyl (DNP) IgE and DNP-BSA, and then using the conditioned medium to stimulate rat conjunctival fibroblasts. Chemokines (eotaxin-1, IL-8, and RANTES - Regulated and Normal T cell Expressed and Secreted) released from cells into the medium was determined by ELISA. Human conjunctival fibroblasts and epithelial cells were also directly stimulated with exogenous cytokines tumor necrosis factor (TNF)-α or IL-4. Degradation of IκB-α and phosphorylation of STAT6 were assessed by immunoblotting. For inhibition of NFκB or STAT6 activation, upstream regulators IκB kinase and Janus protein tyrosine kinases (JAK) were inhibited by use of BMS-345541 and JAK inhibitor 1. An in vivo model of conjunctivitis was also produced in rats by intraperitoneal injection of ovalbumin (OA) with aluminum hydroxide and challenge at 21d with OA eye drops. Results: Stimulated rat mast cells released TNF-α and IL-4. TNF-α induced NFκB activation in rat and human conjunctival fibroblasts and epithelial cells, and caused production and release of cytokines IL-8 and RANTES. IL-4 activation of STAT6 did not cause release of these cytokines. Only fibroblasts produced the eosinophil-recruiting cytokine, eotaxin-1, after treatment with TNF-α- plus IL-4. As observed in the cultured cells, allergic stimulation in the in vivo model caused degradation of IκB-α in conjunctiva, and infiltration of eosinophils and other inflammatory cells. Conclusion: Activated NFκB was found to be a major transcription factor for the release of cytokines from conjunctival cells and intensification of the allergic response. Inhibition of the NFκB pathway by therapeutic drugs may be an important objective for the treatment of human allergic conjunctivitis.

KW - Allergic conjunctivitis

KW - Chemokine

KW - Conjunctival cells

KW - Mast cells

KW - NFκB

UR - http://www.scopus.com/inward/record.url?scp=84879592143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879592143&partnerID=8YFLogxK

U2 - 10.3109/02713683.2013.780623

DO - 10.3109/02713683.2013.780623

M3 - Article

C2 - 23621293

AN - SCOPUS:84879592143

VL - 38

SP - 825

EP - 834

JO - Current Eye Research

JF - Current Eye Research

SN - 0271-3683

IS - 8

ER -